Loading
Latest filing published 21 Apr 2025 for Enfusion, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Oleg Movchan is a declared insider of Enfusion, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 23 filings, for trades running from 11 May 2022 to 21 April 2025.
No open-market purchase appears, only 7 sales worth €2.5M. The rest of the record consists of 8 share grants. In 2025 alone, the filings show no purchases and 3 sales.
Most recently, on 21 April 2025, the filings show a transaction in Enfusion, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations